Company context
The company provides technical assurance, laboratory, monitoring and compliance-support services to organisations that must demonstrate environmental performance. Revenue may arise from recurring programmes, site assignments, laboratory activity, multi-location contracts, specialised studies and project-linked deliverables. The operating model combines scientific judgement, field execution, controlled sample and data handling, technical review, report issuance and customer collection.
The business is preparing for an initial public offering. Its Board must ensure that rapid growth, acquisitions, service-line expansion and decentralised delivery have not produced inconsistent accounting, unsupported revenue, weak sample-to-invoice traceability or an overstated view of recurring earnings.
Board mandate
The Independent Director will lead financial-audit readiness from the economics of each engagement through the financial statements and offer documentation. The role will connect revenue quality, technical delivery evidence, receivables, laboratory utilisation, acquisition accounting, internal controls and disclosure governance.
The director must be comfortable challenging both financial and technical leaders. A signed customer work order is not sufficient evidence of revenue; a completed technical report is not sufficient evidence of collectability; and statutory audit completion is not sufficient evidence that controls are scalable for public ownership.
Strategic and governance priorities
- Define revenue-recognition policies by engagement type, identifying enforceable rights, performance obligations, delivery evidence, acceptance, variable consideration, modifications and cancellation exposure.
- Establish traceability from customer contract and approved scope through field work, sample custody, laboratory processing, technical review, report release, invoicing, credit note and collection.
- Separate recurring, repeat, project-based, pass-through and one-time revenue so the Board and prospective investors understand earnings quality without promotional classification.
- Review unbilled revenue, contract assets, deferred revenue, mobilisation advances, retention and aged receivables through customer-level evidence and subsequent collection.
- Govern principal-versus-agent assessment for outsourced laboratories, field partners, equipment providers and specialist consultants.
- Strengthen controls over sample identity, chain of custody, test authorisation, result changes, report versioning and linkage between operational systems and billing systems.
- Review laboratory equipment, calibration, maintenance, impairment, useful life and utilisation; prevent capital expenditure from masking weak service-line economics.
- Examine acquisition accounting, contingent consideration, goodwill, customer relationships, earn-outs, related parties and integration costs with realistic impairment triggers.
- Establish an IPO control-remediation office with risk-ranked deficiencies, accountable owners, interim controls, evidence standards and independent closure testing.
- Challenge adjusted performance measures, pro-forma results, market-share claims, recurring-revenue descriptions, capacity claims and use-of-proceeds disclosure.
- Protect auditor independence and ensure that statutory audit, internal audit, tax diligence, financial diligence and offer-document procedures have clear, non-duplicative accountability.
- Prepare the finance organisation for quarterly close, public disclosure, analyst scrutiny, insider controls and the first annual-report cycle.
IPO decisions expected at Board level
- Whether the control environment is mature enough to file, or whether remediation should delay the timetable.
- Whether a material category of unbilled revenue has sufficient delivery and collection evidence.
- Whether acquired growth can be presented as comparable with organic growth.
- Whether a service line described as recurring is supported by contractual or behavioural evidence.
- Whether an identified technical-integrity event requires financial provision, customer notification or disclosure.
- Whether offer-document claims are traceable to controlled, current and consistently defined source data.
Audit Committee leadership agenda
- Approve accounting position papers before they enter filing documents.
- Review close readiness, audit adjustments, control deficiencies and unresolved diligence matters at each IPO stage gate.
- Hold private sessions with auditors and technical-assurance leaders.
- Track source ownership for every material financial and operating statement in the offer document.
- Establish the post-listing Audit Committee calendar before filing, not after admission.
Candidate profile
Essential: Former CFO, audit partner, controller, internal-audit leader or financially sophisticated CEO with IPO, listed-company or regulated-services experience; direct responsibility for revenue recognition, consolidations, acquisition accounting, internal financial controls and auditor engagement; demonstrated ability to chair difficult discussions about filing readiness and financial evidence.
Preferred: Technical, laboratory, certification, engineering, compliance or project-services businesses; multi-entity finance; offer-document diligence; acquired-business integration; public-company quarterly reporting; forensic or control-remediation oversight.
Eligibility, independence and conflicts
Active inclusion in the IICA Independent Directors Databank is mandatory. Candidates must have completed the applicable proficiency test or hold a documented exemption and satisfy all applicable independence, DIN, KYC, disqualification, tenure and committee-capacity requirements.
Candidates must disclose relationships with customers, laboratories, technical consultants, regulators, auditors, issue advisers, lenders, private-equity or venture investors, acquisition targets and competitors. No candidate should accept the mandate where prior advisory work creates self-review risk over accounting positions, controls or IPO disclosures.
First 100 days
- Approve the IPO financial-reporting risk map and accounting-position calendar.
- Select material engagement types for contract-to-cash walkthroughs.
- Review revenue, receivables, acquisitions and control deficiencies with auditors.
- Define filing readiness gates and matters reserved for Audit Committee clearance.
First-year outcomes
- Defensible revenue and cash-quality reporting across all material engagement types.
- A tested control environment capable of public-company closing and disclosure.
- No unsupported financial, recurring-revenue or capacity claims in filing materials.
- Independent closure of high-risk control deficiencies before listing.